Trevor Allred
Stock Analyst at Oppenheimer
(2.87)
# 1,806
Out of 5,044 analysts
4
Total ratings
71.43%
Success rate
21.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Trevor Allred
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences | Maintains: Outperform | $38 → $80 | $17.44 | +358.72% | 2 | Sep 23, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Outperform | $85 | $70.25 | +21.00% | 1 | Sep 9, 2025 | |
| INVA Innoviva | Initiates: Outperform | $35 | $17.72 | +97.52% | 1 | Aug 11, 2025 |
MBX Biosciences
Sep 23, 2025
Maintains: Outperform
Price Target: $38 → $80
Current: $17.44
Upside: +358.72%
Palvella Therapeutics
Sep 9, 2025
Initiates: Outperform
Price Target: $85
Current: $70.25
Upside: +21.00%
Innoviva
Aug 11, 2025
Initiates: Outperform
Price Target: $35
Current: $17.72
Upside: +97.52%